Through the partnership, Summit made a $250 million investment, which is a combination of equity and debt, in DMG. Proceeds will be used to support growth initiatives at DMG’s practice management company.
Under the agreement with Summit, DuPage Medical Group will remain physician-owned-and-directed.
“For an independent, physician-led group of DMG’s scale and size to retain its majority ownership after such a significant investment is unprecedented,” said DuPage Medical Group CEO Mike Kasper. “Summit Partners understands that our patient-focused, doctor-directed culture is crucial to our mission, and they are completely supportive of it. This partnership provides access to capital and strategic support for DMG’s growth initiatives — including population health, expansion into new geographies and opening additional clinical lines of service — and will help to enhance our ability to reach and treat patients.”
More articles on healthcare finance:
Illinois hospital closes; OSF Healthcare converts building into urgent care center
Steward’s losses mount as system takes a long-term view
Missouri hospital to close this month as BJC consolidates services
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
